Access cutting-edge breast cancer treatment through this clinical trial at a research site in Hartford. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Hartford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This phase II trial studies how well nab-paclitaxel, durvalumab, and tremelimumab with or without personalized synthetic long peptide vaccine (neoantigen vaccine) works in treating patients with triple negative breast cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopp
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this breast cancer clinical trial in Hartford, CT
If you're searching for breast cancer treatment options in Hartford, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hartford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.